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Abstract
Objective: To study ultra-early pathophysiological changes of rabbit acute lung injury (ALI) caused by paraquat
(PQ) and discuss the ultra-early protective effect of ulinastatin on rabbit ALI due to PQ.
Methods: 30 New Zealand white rabbits were randomly divided into a control group, a paraquat group and an
ulinastatin intervention group with 10 rabbits in each group. For paraquat group and intervention group a single
dose of paraquat (35mg/kg) was injected intraperitoneally to establish rabbit models of ALI. The control group was
injected an equal volume of saline. The intervention group was treated with 100Ku/kg ulinastatin immediately after
the establishment of the ALI model. The respective experimental groups underwent 320-slice CT perfusion scan of
pleural at 2h, 4h and 6h time point after modeling to get CTP (CT Perfusion) images and related parameters. 2mL
blood was collected in the marginal ear vein to determine the mass concentration of the vascular endothelial
growth factor (VEGF). The animals were killed by air embolism after 6h and lung tissue was taken for pathology
observation.
Results: The reginal blood flow (rBF) and reginal blood volume (rBV) of paraquat group at 2,4,6 h time point were
significantly (P <0.05) lower than those of control group. The intervention group rBF and rBV at 2, 4 and 6 h time
points were significantly higher (P <0.05) compared to paraquat group. The permeability surface (rPS) and VEGF
mass concentration of paraquat group at 2,4,6 h time point were significantly higher than the control group (P
<0.05), and the intervention group rPS and VEGF mass concentrations at 2,4,6h time point were significantly lower
(P <0.05) than those of paraquat group. Pathological detection indicators of paraquat group (congestive capillary
percentage, the number of red blood cells outside of capillaries, percentage of capillaries with basement
membrane damage) were significantly higher (P <0.05) at 6h time point compared with the control group, while
significantly lower (P <0.05) in intervention group than in paraquat groups. Pathological observation under light
microscope showed in paraquat group obvious inflammatory cell infiltration, alveolar epithelial cell hyperplasia,
widened alveolar septum, visible focal hemorrhage, visible acute and chronic inflammatory cell infiltration in
bronchioles cavity; under electron microscopy alveolar epithelial cell degeneration and necrosis, vascular welling of
the endothelial cells, basement membrane rupture, a lot of exudates in alveolar space. In the intervention group,
the above the symptoms were mitigated.
Conclusion: In the ultra-early stage of rabbit ALI induced by PQ, pulmonary vascular endothelial cell is damaged
and serum VEGF mass concentration and pulmonary vascular permeability increase. Early ulinastatin intervention
can reduce serum VEGF level and PQ-induced vascular permeability amplitude, indicating that ulinastatin has a
protective effect on pulmonary vascular endothelial cells.
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Introduction
Acute lung injury (ALI) is acute progressive dyspnea and
refractory hypoxemia caused by a variety of lung internal
and external factors. The basic pathological changes are
acute inflammatory response and increase of pulmonary
microvascular permeability. Ulinastatin is an urinary tryp-
sin inhibitor isolated from male urine and it can inhibit
the release of a variety of inflammatory mediators. In
recent years, ulinastatin was widely used in the treatment
of a variety of severe diseases[1]. It has been reported that
early application of ulinastatin can reduce the symptoms
of ALI [2], but the mechanism is not fully elucidated. 320-
Slice CT is the world’s most advanced imaging equipment,
and is currently the only CT that can achieve dynamic
volume scan imaging with functional imaging characteris-
tics. This article intents to explore the protective effect of
ulinastatin on lungs at ultra-early ALI stage and provide
the experimental basis for clinical treatment through
establishment of rabbit ALI model by paraquat poisoning
and 320-slice CT imaging technology to observe diseased
lung function status and blood flow situation as well as




Paraquat aqueous solution was purchased from Chuan-
dong Agrochemical Co., Ltd. (active ingredient content of
200g / L, the production license number: XK13-003-
00058); 320-slice CT was purchased from Toshiba Cor-
poration, Japan; VEGF kit was purchased from Beijing
Dongge reagents Limited; Optical microscope (CX31RTSF
type) was purchased from Olympus Corporation; Electron
microscopy equipment was provided by the fourth Mili-
tary Medical University, Institute of Neurobiology.
Animal grouping
Thirty healthy New Zealand white rabbits, 3-6 months of
age, body weight between 2.0-2.5kg, both male and female,
were provided by the Beijing Haidian District Xinglong
experimental animal breeding plant, the Certificate No.
SCXK (Beijing) 2010-0011. The animals were randomly
divided into three groups: control group, paraquat group,
ulinastatin intervention group, with ten rabbits in each
group.
Model preparation
Referenced by Piao Zhiyong et al [3] rabbit ALI model-
ing method, a single dose of 35mg/kg paraquat was
intraperitoneally injected to paraquat group and ulinas-
tatin intervention group respectively and the control
group was injected an equal volume of saline instead.
Animal behavior was observed to confirm successful
modeling. In intervention group immediately after the
establishment of the ALI model, 100Ku/kg ulinastatin was
dissolved in 20 mL of saline for slow bolus in ear vein.
Sample collection and indicator detection
Each experimental group underwent lipiodol perfusion
(2ml) in the marginal ear vein after modeling 2,4 and
6 hours followed by immediate 320-slice CT scan of
pleural. Images were acquired automatically and image
analysis took middle and lower lung level CTP parameters
from the same rabbit, avoiding the heart and diaphragm
artifact interference. Blood (2ml) was collected at various
time points in the marginal ear vein and centrifuged under
3000r/min for 10 minutes. The supernatant was used for
VEGF mass concentration measurement with VEGF kit,
strictly in accordance with the manual operation. After
6 hours animals were killed by air embolism and small
piece of the right upper lobe tissue was taken for pathol-
ogy observation under light and electron microscopy.
Under light microscope, 10 fields were taken randomly for
each sample at × 40 magnification vision. With image ana-
lysis software, the numbers of red blood cells outside the
capillary were calculated and averages per field were
taken. At × 10 magnification, 10 fields were randomly
selected to calculate the percentage of congestive capil-
laries in the total number of capillaries within fields.
Under electron microscope, percentages of capillaries with
damaged basement membrane in the total number of
capillaries in the same sample were calculated.
Statistical methods
SPSS 14.0 statistical software was used for experimental
data analysis and measurement data was presented as
mean ± standard deviation ( )x  s form. One-way
ANOVA was used for comparison between groups (LSD
test for homogeneity of variance and Games-Howell test




Control group rabbits were full of energy, lively, breathing
and heartbeat smooth; paraquat group of rabbits soon
after exposure looked quiet without much movement,
malaise, anorexia, shortness of breath, rapid heartbeat, and
a few hours later showed lips cyanosis, twitching limbs
and extrados; Ulinastatin intervention group of rabbit had
relieved symptoms and did not appear cyanotic lips and
convulsion.
CTP parameter changes
For the same group of animals under the same parameter
conditions, in the control group, perfusion images over
time did not change significantly (Figure 1), indicating
the lung perfusion in good condition. In paraquat group,
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perfusion image color changed the most (Figure 2), indi-
cating that lung perfusion changed significantly over
time, suggesting poor lung perfusion and heavy tissue
damage. Ulinastatin intervention group image changes
were slightly smaller than paraquat group (Figure 3),
indicating that the lung perfusion changed slightly, sug-
gesting that lung injury was lighter. Comparison of mid-
dle and lower lung level CTP parameters from the same
rabbit showed that differences among paraquat group,
control group and ulinastatin intervention group were
statistically significant (P <0.05), shown in Table 1.
Changes in serum VEGF
Compared with the control group, paraquat group serum
VEGF mass concentrations at 2,4,6 h time point were sig-
nificantly higher (P <0.05); Compared with paraquat
group, ulinastatin intervention group serum VEGF mass
concentrations at 2,4,6 h time point were significantly
lower (P <0.05), as shown in Table 2.
Pathology detection indicators
After 6 hours, pathology indicators became significantly
abnormal. In paraquat group congestive capillary percen-
tage, number of red blood cells outside of capillaries and
percentage of capillaries with damaged basement mem-
brane were significantly higher than those of the control
group (P <0.05), while the above values of ulinastatin
intervention group increased slightly, with a significant dif-
ference (P <0.05) from paraquat group. The relevant indi-
cator test results are shown in Table 3.
The pathological changes of the lung tissue
Light microscope observation
In control group, the basic structure of lung tissue was
normal and alveolar structure was clear, no congestion,
edema and inflammatory changes (Figure 4). In paraquat
group, there was obvious lung tissue inflammatory cell
infiltration, alveolar epithelial cell hyperplasia, widened
alveolar septa, significant bronchiolar mucosal epithelial
Figure 1 From left to right, CTP images of the same rabbit in control group at 2h, 4h, 6h time points, respectively. There were no significant
changes, indicating good lung perfusion and no lung injury.
Figure 2 From left to right, CTP images of the same rabbit in paraquat group at 2h, 4h, 6h time points, respectively. The color changed most,
indicating that pulmonary perfusion changed significantly over time, suggesting heavy lung tissue damage.
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hyperplasia, spotty accumulation of lymphocytes, visible
acute and chronic inflammatory cell infiltration within
lumen, visible focal hemorrhage for part of lung tissue
(Figure 5). Compared with paraquat group, the above
symptoms in ulinastatin intervention group were reduced
and there was no pulmonary hemorrhage (Figure 6).
Electron microscope observation
There was no abnormal change of ultrastructures in con-
trol group (Figure 7). The damage is obvious in paraquat
group: type I alveolar epithelial cell vacuolization, degen-
eration and necrosis, type II alveolar epithelial cells swel-
ling, obvious lamellar body emptying, large amount of
microvilli shedding, a large number of vascular neutrophils,
vascular endothelial cell swelling, basement membrane
rupture, a large number of plasma-like exudates, red blood
cells, granulocytes and necrotic cell debris in alveolar space
(Figure 8). Ultrastructural changes of intervention group
were smaller than those of paraquat group, vascular base-
ment membrane was relatively complete, endothelial cell
swelling was not obvious and exudate in alveolar cavity
was less (Figure 9).
Discussions
Acute lung injury (ALI) and its more severe stage of
acute respiratory distress syndrome (ARDS) are caused
by a variety of reasons both within and outside the lung
characterized by progressive dyspnea and refractory
hypoxemia. They are acute syndromes caused by body
excessive inflammatory response. Endothelial cell damage
and dysfunction are important pathological features of
ALI / ARDS [4]. It is manifested as extensive damage of
pulmonary vascular endothelial cells and alveolar epithe-
lial as well as increase of pulmonary vascular permeabil-
ity[5]. Ulinastatin is a urinary trypsin inhibitor isolated
from male urine. It is a glycoprotein with typical Kuniz
protease inhibitor structure. It has two completely non-
overlapping active function areas and both have a broad
spectrum of enzyme inhibition activity[6]. It has been
confirmed that ulinastatin can simultaneously inhibit
trypsin, hyaluronidase, elastase, phospholipase A2 and
other varieties of hydrolytic enzymes [7]. It can also inhi-
bit the release of inflammatory mediators and reduce the
Figure 3 From left to right, CTP images of the same rabbit in Ulinastatin intervention group at 2h, 4h, 6h time points, respectively. The image
changes were slightly smaller than paraquat group, indicating that the lung perfusion changed slightly, suggesting that lung injury was lighter.
Table 1 CTP parameter changes of each experimental
group at different time points( )x  S
CTPparameter Group 2h 4h 6h




















rBV control group 14.25±1.75 14.32±1.70 14.56±1.91




rPS control group 21.27±1.28 21.28±1.44 21.77±1.69










Note: At the same time point paraquat group compared with the control group
*P <0.05, the intervention group compared with paraquat group ▲P<0.05.
(unit, rBF: ml/min/100ml,rBV:ml/100ml,rPS:ml/min/100ml)
Table 2 Comparison of serum VEGF mass concentrations of
experimental groups at different time points ( )x  S, ng/L
Group n 2h 4h 6h
Control group 10 42.35±6.12 43.21±5.49 42.67±4.97
paraquat group 10 167.52±18.83* 257.98±20.62* 343.98±21.76*
intervention group 10 110.04±16.05▲ 183.33±17.45▲ 269.79±20.7▲
Note: At the same time point paraquat group compared with the control
group * P <0.05, the intervention group compared with paraquat group
▲P<0.05.
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damage of inflammatory factor on target organs. Ulinas-
tatin intervention of ALI is a research focus in recent
years and studies have shown that ulinastatin can reduce
symptoms of ALI, but its mechanism of action is unclear.
320-slice CT perfusion scan is a noninvasive func-
tional imaging method [8]. CTP images were achieved
by intravenous infusion of contrast agent and dynamic
scanning to a particular level. Perfusion parameters such
as rBF, rBV and rPS were obtained by computer proces-
sing and they can reflect hemodynamic changes in the
capillary level to assess tissue and organ perfusion stage.
In this paper, a single intraperitoneal injection of para-
quat aqueous solution was used to establish ALI models
and ulinastatin was used for ultra-early intervention.
320-Slice CT perfusion technology was applied for scan
observation of blood flow changes in the early stages of
ALI. Changes in serum VEGF levels and pathology
detection indicators were combined to understand
microvascular changes after ulinastatin intervention at
ALI ultra-early stages and to explore early protective
effect of ulinastatin on PQ-induced ALI in rabbits.
During experiments, we found that paraquat group ani-
mals appeared quiet without much movement, malaise,
anorexia, shortness of breath, rapid heartbeat and other
behavioral changes after exposure, in line with paraquat
poisoning signs. Two, four, and six hours after exposure,
lipiodol perfusion was followed by 320-slice CT scan of
the chest. There was distinct color change of perfusion
images with time in paraquat group, indicating that lung
perfusion changed significantly over time, suggesting pos-
sible heavy lung tissue damages result in poor lung perfu-
sion. Determination of CTP parameters found that in
paraquat group rBF and rBV decreased with time, while
rPS gradually increased with time. rBF reduction indicated
blood rate declined in lung tissue; rBV reduction indicated
blood capacity within the lung tissue vasculature
decreased; rPS elevation suggested the rate of blood uni-
directionally going into the tissue space through capillary
endothelial cells increased. Three parameter values at the
same time point showed a significant difference (P <0.05)
compared with the control group. The results verified the
changes in the perfusion image, indicating poor lung
Table 3 Pathological test results of experimental groups at 6h time point
Group Congestive capillary
percentage
The number of red blood cells outside the
capillary
The percentage of capillaries with damaged basement
membrane
Control group 0.98±1.31 2.1±0.99 0




Note: At the same time point paraquat group compared with the control group * P <0.05, the intervention group compared with paraquat group ▲P<0.05.
Figure 4 Control group animal’s lung tissue structure, alveolar structure clear, no inflammatory cell infiltration (HE×400)
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Figure 5 paraquat group animal’s lung tissue structure.
Figure 6 ulinastatin intervention group animal’s lung tissue structure a large number of inflammatory cell infiltration, focal hemorrhage (HE×400)
no bleeding point (HE×400).
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perfusion at early ALI stage. This revealed ultra early
hemodynamic characteristics of acute lung injury induced
by paraquat. Ulinastatin group images showed little differ-
ence at the 2h time point from the control group, while
significant difference at 4 and 6 hour time points. The
former may be because paraquat absorption was small and
ulinastatin produced direct effect right after entering into
the blood. In the latter case, paraquat absorption increased
with time and enhanced lung tissue damage, while ulinas-
tatin content in blood reduced due to metabolism and
Figure 7 control group vascular basement membrane was complete, no swelling of endothelial cell (× 10K).
Figure 8 Paraquat group type I alveolar epithelial cell vacuolization structure.
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lung damage gradually intensified. Compared with para-
quat group, ulinastatin group still showed significantly bet-
ter image changes. The magnitude of rBF, rBV decline and
rPS increase were smaller and there were significant differ-
ences (P <0.05) compared with the paraquat group. The
changes on the imaging suggest some treatment effect of
ulinastatin.
Previous studies have shown that VEGF is a multifunc-
tional cytokine and can regulate endothelial cell survival,
proliferation, migration, angiogenesis, vascular permeabil-
ity and mononuclear cell recruitment[9]. Under normal
state VEGF expresses abundantly in alveolar epithelium,
bronchial epithelium and bronchial gland cells and the
level of VEGF in normal human respiratory alveolar fluid
is 500 times more than in serum[10], but under normal
circumstances it is not released directly into blood. The
increasing effect of VEGF on vascular permeability is
extremely strong and its effect is 20,000 times more
powerful than histamine [11]. Therefore, VEGF is one of
the markers to determine the degree of endothelial cell
injury and vascular permeability. In this experiment,
VEGF mass concentration of paraquat group elevated
sharply over time. Compared with control group, there
was a significant difference (P <0.05), indicating that
endothelial cell damage occurs at ALI ultra-early stage and
vascular permeability increases. After ulinastatin interven-
tion, VEGF mass concentrations increased to a lesser
extent. Compared with paraquat group there was signifi-
cant differences (P <0.05), suggesting ulinastatin can
reduce the damage of endothelial cells, inhibit the release
of VEGF and reduce vascular permeability, which verified
image changes from the cellular level.
Pathological observation showed that in paraquat
group animals lung tissue had significant acute inflam-
matory changes, while ulinastatin intervention group had
less inflammatory injury, which is consistent with pathol-
ogy detection indicators. Pathology results also well
explained the changes in the imaging and VEGF mass
concentration. From comprehensive analysis, pathophy-
siological change at ALI ultra-early stage is vascular
endothelial injury, and the exposed endothelial can easily
form a local microthrombi which affects blood flow and
blood volume, expressed as the decline in rBF and rBV.
Endothelial injury prompts VEGF release in large quanti-
ties into the blood. The concentration, vascular perme-
ability and rPS increase, resulting in a large number of
liquid into the tissue space, alveolar septum widened and
various excessive inflammatory cell infiltration to the
local tissue and aggravating tissue damage. The experi-
ments showed that early application of ulinastatin can
Figure 9 Ulinastatin intervention group endothelial cell swelling was not obvious, Neutrophils and red blood exudation in alveolar space。
(× 10K) Relative complete vascular basement membrane, a small amount of exudate in alveolar cavity (× 5K)
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significantly change the status of ALI ultra-early patho-
physiology. It is expressed as significant improvement of
vascular permeability at ALI early stage, suggesting that
its mechanism should be related to reducing endothelial
cell damage and lowering serum VEGF content. This is
consistent with findings of Cai Shi Xia et al [12]about uli-
nastatin on pulmonary microvascular permeability in
septic rats.
From experimental results, at ultra-early ALI stage, uli-
nastatin can mitigate vascular endothelial injury, reduce
serum VEGF content and elevation level of pulmonary
vascular permeability, lower migration and infiltration of
inflammatory cells, thereby reducing the degree of lung
injury and playing a role in lung protection. Studies[13,14]
also showed that ulinastatin can directly inhibit the release
of neutrophils and other inflammatory mediators, thereby
reducing damage to the endothelial cells and reducing
capillary permeability. Therefore, it is further speculated
that ulinastatin on one hand can protect endothelial cells
and reduce the expression of VEGF in lung tissue to inhi-
bit neutrophil infiltration, on the other hand can directly
inhibit damage of neutrophils to endothelial cell to reduce
VEGF release. They promote and influence each other and
the specific mechanism still needs further study.
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